Press Release

Muno-IgY shows significant potential for reducing Upper Respiratory Tract Infections

2023-12-13T20:01:36+00:00

Press Release  |  December 12, 2023 Thunder Bay, Ontario, Canada - December 12, 2023 – IGY Life Sciences and Immune Technologies Inc. (the "Company" or "IGY Life Sciences") is pleased to announce results from a pilot study to evaluate the effects of Muno-IgY on immune function in healthy adult volunteers. The study sought [...]

Muno-IgY shows significant potential for reducing Upper Respiratory Tract Infections2023-12-13T20:01:36+00:00

IGY Life Sciences announces the closing of $12.8 million (CDN) in new funding to meet high product demand

2023-07-11T20:12:57+00:00

Press Release  |  March 24, 2023 Thunder Bay, Ontario, Canada - July 25, 2022 – IGY Life Sciences and Immune Technologies Inc.(the "Company" or "IGY Life Sciences") is pleased to announce the closing of $12.8 million (CDN) in financing this week. This represents the largest single injection of funds into the Company since it [...]

IGY Life Sciences announces the closing of $12.8 million (CDN) in new funding to meet high product demand2023-07-11T20:12:57+00:00

IGY Life Sciences achieves 94.8% purity of IgY, opening the way for large-scale health applications for Nutraceuticals

2023-07-11T20:13:36+00:00

Press Release  |  July 25, 2022 Thunder Bay, Ontario, Canada - July 25, 2022 – IGY Life Sciences and Immune Technologies Inc. (the "Company" or "IGY Life Sciences") is pleased to announce it has reached 94.8% purity of Muno-IgYTM, the Company’s branded nutraceutical IgY ingredient for targeting immune and gut health through supplementation of [...]

IGY Life Sciences achieves 94.8% purity of IgY, opening the way for large-scale health applications for Nutraceuticals